Compare Charles River Laboratories Intl. Inc (CRL) vs Centrus Energy Corp (LEU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Centrus Energy Corp — how do they compare? Charles River Laboratories Intl. Inc trades at $302.69 (market cap $14.23B), while Centrus Energy Corp trades at $142.31 (market cap $2.91B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 4.9× Centrus Energy Corp's market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Centrus Energy Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Centrus Energy Corp for 29 Days on average.
| CRL | LEU | |
|---|---|---|
Market Cap | $14.23B | $2.91B |
Volume | 1,176,885 | 903,777 |
Sector | Health | Energy |
52-Week High | $310.77 | $436.00 |
52-Week Low | $149.93 | $138.18 |
Typical Hold Time | 33 Days | 29 Days |
Enterprise Value | $17.06B | $2.22B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $300.53, up 0.08% on the day, with a bullish technical outlook and strong analyst support. The stock has consistently beaten earnings estimates in recent quarters, though it faces profitability challenges with a negative net income margin and ROE. Recent investor day presentations highlighted a strategic plan targeting 5-7% revenue growth and $300 million in savings by 2030, driving positive sentiment.
The outlook is cautiously optimistic, supported by analyst buy ratings and a $305.50 consensus price target, but risks include ongoing margin pressure, volatile non-human primate costs, and a high valuation multiple. Earnings growth and successful execution of the new strategic plan are critical for sustained upside.
Centrus Energy (LEU) trades at $141.28, down 3.98% on the day, with a bearish technical outlook despite recent earnings beats. The stock shows elevated valuation metrics (P/E 75.18, P/S 6.68) but benefits from strong nuclear energy tailwinds and multiple HALEU supply contracts. Recent news highlights Centrus as a key player in the domestic nuclear fuel supply chain, with analyst consensus pointing to significant upside potential from current levels.
The investment case balances high execution risk against substantial growth opportunities in nuclear fuel enrichment. While profitability metrics show pressure (net margin declining to 10.23%), the company's strategic positioning in HALEU production and federal support create compelling long-term potential. Key risks include operational execution, valuation sensitivity, and nuclear industry adoption timelines.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Centrus Energy Corp
Centrus Energy is a leading supplier of nuclear fuel and services for the global power industry. It specializes in supplying low-enriched uranium and developing next-generation fuels for advanced nuclear reactors.
Read more on LEU →
